Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
, 8 (1), 7

Drug Transport in Brain via the Cerebrospinal Fluid

Affiliations
Editorial

Drug Transport in Brain via the Cerebrospinal Fluid

William M Pardridge. Fluids Barriers CNS.

Abstract

The human brain has no lymphatic system, but produces over a half-liter each day of cerebrospinal fluid. The cerebrospinal fluid is secreted at the choroid plexus and occupies the cavities of the four ventricles, as well as the cranial and spinal sub-arachnoid space. The cerebrospinal fluid moves over the surfaces of the brain and spinal cord and is rapidly absorbed into the general circulation. The choroid plexus forms the blood-cerebrospinal fluid barrier, and this barrier is functionally distinct from the brain microvascular endothelium, which forms the blood-brain barrier. Virtually all non-cellular substances in blood distribute into cerebrospinal fluid, and drug entry into cerebrospinal fluid is not an index of drug transport across the blood-brain barrier. Drug injected into the cerebrospinal fluid rapidly moves into the blood via bulk flow, but penetrates into brain tissue poorly owing to the limitations of diffusion. Drug transport into cerebrospinal fluid vs. brain interstitial fluid requires knowledge of the relative expression of transporters at the choroid plexus versus the brain microvascular endothelium.

Similar articles

See all similar articles

Cited by 60 PubMed Central articles

See all "Cited by" articles

References

    1. Oldendorf WH. Cerebrospinal fluid formation and circulation. Prog Nuc Med. 1972;1:336–358. - PubMed
    1. Davson H. The Cerebrospinal Fluid. Handbook of Neurochemistry. 1969;2:23–48.
    1. Dohrmann GJ. The choroid plexus: a historical review. Brain Res. 1970;18:197–218. doi: 10.1016/0006-8993(70)90324-0. - DOI - PubMed
    1. Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res. 2008;25:1469–1483. doi: 10.1007/s11095-008-9532-4. - DOI - PubMed
    1. Yarchoan R, Broder S. Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. N Engl J Med. 1987;316:557–564. doi: 10.1056/NEJM198702263160925. - DOI - PubMed

Publication types

Feedback